Document is current
Any future updates will be listed below
-
Authors
Bondarenko, Valeriia
Løkke, Cecillie Reynolds
Dobrowolski, Peter
Mentzel, Caroline Junker https://orcid.org/0000-0003-4688-7367
Castro-Mejía, Josué L. https://orcid.org/0000-0002-1416-8205
Hansen, Camilla Hartmann Friis https://orcid.org/0000-0002-1860-385X
Sørensen, Dorte Bratbo https://orcid.org/0000-0002-6144-1710
Nielsen, Dennis Sandris https://orcid.org/0000-0001-8121-1114
Krych, Lukasz https://orcid.org/0000-0003-3224-1346
Hansen, Axel Kornerup https://orcid.org/0000-0003-1575-2507
-
Funding
Funding for this research was provided by:
3R Centre Denmark (The Mouse Passport, The Mouse Passport, The Mouse Passport)
GVG Genetics
LIFEPHARM (Postdoc No 9)
- License Information
-
More Information
Article History
Received: 8 November 2021
Accepted: 22 July 2022
First Online: 12 August 2022
Competing interests
: AKH declares that he has collaborated with pharmaceutical industry and received funding from this source, as well as he is the owner of a diabetes related patent as described on . CHFH declares that she has received funding and collaborated with private enterprises as described on . DBS declares that she has received funding and collaborated with private enterprises as described on . VB is today an employee at the pharmaceutical company Lundbeck A/S. Other authors declares no competing interests.
